Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2013, Article ID 686329, 6 pages
http://dx.doi.org/10.1155/2013/686329
Clinical Study

Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis

1Department of Dermatology and Venereology, Ain Shams University, Abasseya Square, Cairo, Egypt
2National Research Center, El-Tahrir Street, Dokki, Giza 12622, Egypt

Received 6 July 2013; Accepted 6 September 2013

Academic Editor: Lajos Kemeny

Copyright © 2013 Hanan Mohamed El Kahky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Aghaei, “Botulinum toxin therapy for palmar hyperhidrosis: experience in an Iranian population,” International Journal of Dermatology, vol. 46, no. 2, pp. 212–214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Talarico-Filho, M. Mendonça do Nascimento, F. Sperandeo de Macedo, and C. de Sanctis Pecora, “A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis,” Dermatologic Surgery, vol. 33, no. 1, pp. S44–S50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Wollina and T. Karamfilov, “Botulinum toxin A for palmar hyperhidrosis,” Journal of the European Academy of Dermatology and Venereology, vol. 15, no. 6, pp. 555–558, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Kranz, D. Haubenberger, B. Voller et al., “Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind study,” Movement Disorders, vol. 24, no. 2, pp. 231–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. R. Trindade de Almeida, L. C. Secco, and A. Carruthers, “Handling botulinum toxins: an updated literature review,” Dermatologic Surgery, vol. 37, no. 11, pp. 1553–1565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Grunfeld, C. A. Murray, and N. Solish, “Botulinum toxin for hyperhidrosis: a review,” American Journal of Clinical Dermatology, vol. 10, no. 2, pp. 87–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Haider and N. Solish, “Focal hyperhidrosis: diagnosis and management,” Canadian Medical Association Journal, vol. 172, no. 1, pp. 69–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. R. Bentivoglio, T. Ialongo, F. Bove, F. de Nigris, and A. Fasano, “Retrospective evaluation of the dose equivalence of Botox and Dysport in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story,” Neurological Sciences, vol. 33, no. 2, pp. 261–267, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Ranoux, C. Gury, J. Fondarai, J. L. Mas, and M. Zuber, “Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia,” Journal of Neurology Neurosurgery and Psychiatry, vol. 72, no. 4, pp. 459–462, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Grosse, G. Kramer, and M. Stöhrer, “Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence,” European Urology, vol. 47, no. 5, pp. 653–659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Marchetti, R. Magar, L. Findley et al., “Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study,” Movement Disorders, vol. 20, no. 8, pp. 937–944, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Solish, V. Bertucci, A. Dansereau et al., “A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee,” Dermatologic Surgery, vol. 33, no. 8, pp. 908–923, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Campanati, L. Sandroni, R. Gesuita et al., “Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 8, pp. 917–921, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Y. Finlay and G. K. Khan, “Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use,” Clinical and Experimental Dermatology, vol. 19, no. 3, pp. 210–216, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Simonetta Moreau, C. Cauhepe, J. P. Magues, and J. M. Senard, “A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis,” British Journal of Dermatology, vol. 149, no. 5, pp. 1041–1045, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. N. J. Lowe, D. A. Glaser, N. Eadie, S. Daggett, J. W. Kowalski, and P.-Y. Lai, “Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety,” Journal of the American Academy of Dermatology, vol. 56, no. 4, pp. 604–611, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Karsai and C. Raulin, “Botox and Dysport: is there a dose conversion ratio in dermatology and aesthetic medicine?” Journal of the American Academy of Dermatology, vol. 62, no. 2, pp. 346–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Karsai, R. Adrian, S. Hammes, J. Thimm, and C. Raulin, “A randomized double-blind study of the effect of botox and dysport/reloxin on forehead wrinkles and electromyographic activity,” Archives of Dermatology, vol. 143, no. 11, pp. 1447–1449, 2007. View at Google Scholar · View at Scopus
  19. C. Sampaio, J. Costa, and J. J. Ferreira, “Clinical comparability of marketed formulations of botulinum toxin,” Movement Disorders, vol. 19, supplement 8, pp. S129–S136, 2004. View at Google Scholar · View at Scopus
  20. D. Hexsel, T. Dal'Forno, C. Hexsel, D. Z. do Prado, and M. M. Lima, “A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A,” Dermatologic Surgery, vol. 34, no. 1, pp. 52–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Bihari, “Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm,” Current Medical Research and Opinion, vol. 21, no. 3, pp. 433–438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. L. Dodd, B. A. Rowell, I. S. Vrabas, R. J. Arrowsmith, and P. J. Weatherill, “A comparison of the spread of three formulations of botulinum neurotoxin A as determined by effects on muscle function,” European Journal of Neurology, vol. 5, no. 2, pp. 181–186, 1998. View at Google Scholar · View at Scopus
  23. K. R. Aoki, “A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice,” Toxicon, vol. 39, no. 12, pp. 1815–1820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. R. L. Rosales, H. Bigalke, and D. Dressler, “Pharmacology of botulinum toxin: differences between type A preparations,” European Journal of Neurology, vol. 13, supplement 1, pp. 2–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Pickett, “Dysport: pharmacological properties and factors that influence toxin action,” Toxicon, vol. 54, no. 5, pp. 683–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Yamashita, H. Shimizu, M. Kawada et al., “Local injection of botulinum toxin a for palmar hyperhidrosis: usefulness and efficacy in relation to severity,” Journal of Dermatology, vol. 35, no. 6, pp. 325–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Shargall, E. Spratt, and R. A. Zeldin, “Hyperhidrosis: what is it and why does it occur?” Thoracic Surgery Clinics, vol. 18, no. 2, pp. 125–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Coulson, “Disorders of sweat glands,” in Rook’s Textbook of Dermatology, T. Burns, S. Breathnach, N. Cox, and C. Griffiths, Eds., vol. 2, chapter 44, pp. 931–949, Wiley-Blackwell, Singapore, 8th edition, 2010. View at Google Scholar